Involvement of adenosinergic receptors in anxiety related behaviours

Indian Journal of Experimental Biology

Volumn 45, Issue 5, 2007, Pages 439-443

  Kulkarni, Shrinivas K ^a,b   Singh, Kulwinder ^a   Bishnoi, Mahendra ^b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Adenosine; Caffeine; Zero maze

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; ANXIOLYTIC AGENT; CAFFEINE; THEOPHYLLINE;

ANIMAL; ANIMAL BEHAVIOR; ANXIETY; ARTICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; EVALUATION; FEMALE; MALE; MAZE TEST; MOUSE; MOUSE STRAIN; PHYSIOLOGY;

ADENOSINE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CAFFEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; FEMALE; MALE; MAZE LEARNING; MICE; MICE, INBRED STRAINS; RECEPTORS, PURINERGIC P1; THEOPHYLLINE;

EID: 34547728216     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Snyder S H, Adenosine as a neuromodulator. Annu Rev Neurosci, 8 (1985) 103.
2. Jurgen Deckert, The adenosine A2A receptor knockout mouse: a model for anxiety? Int J Neuropsychopharmacology, 1 (1998) 187.
3. Kulkarni S K & Mehta A K, Purine nucleoside-mediated immobility in mice: Reversal by antidepressants, Psychopharmacology, 85 (1985) 460.
4. Deckert J & Gleiter C H, Adenosinergic psychopharmaceuticals: just an extra cup of coffee? J Psychopharmacol, 41 (1990) 83.
5. Sawynok J & Sweeney M J, The role of purines in nociception. Neuroscience, 32 (1989) 175.
6. Mehta A K & Kulkarni S K, Effect of Purinergic substances on rectal temperature in mice: Involvement of P1- purinoceptors. Arch. Int. de Pharmacodyna et de Therap, 264 (1983) 180.
7. Griffiths R R & Mumford G K, Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans, in Pharmacological aspects of drug dependence, (Chapter 9) edited by C R Schuster & M J Kuhar (Springer Verlag, Berlin) 1996.
8. Chait L D, Factors influencing the subjective response to caffeine, Behav. Pharmacol, 3 (1992) 219.
9. Evans S M & Griffiths R R, Dose-related caffeine discrimination in normal volunteers: individual differences in subjective and self-reported cues, Behav Pharmacol, 2 (1991) 345.
10. Shepherd J K & Grewal S S, Behavioral and pharmacological characterisation of the elevated "zero maze" as an animal model of anxiety, Psychopharmacology, 116 (1994) 56.
11. Kulkarni S K & Reddy, D S, Animal behavioral models for testing antianxiety agents, Meth Find Ext Clin Pharmacol, 18 (1996) 219.
12. Klinger M, Freissmuth M & Nanoff C, Adenosine receptors: G protein mediated signalling and the role of accessory proteins, Cell Signal, 14 (2002) 99.
13. Fredholm B B, Adenosine receptors, in Understanding G protein-coupled receptors and their role in the CNS, edited by M N Pangalos & CH Davies, (Oxford University Press, Oxford, UK) 2002, 191.
14. Dhalla A K, Shryock J C, Shreeniwas R, Belardinelli L, Pharmacology and therapeutic applications of A1 adenosine receptor ligands, Curr Top Med Chem, 3 (2003) 369.
15. Malika El Yacoubi, Catherine Ledent Marc Parmentier & Jean Costentin Jean-Marie Vaugeois, The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A2A adenosine receptor antagonists, Psychopharmacology, 148 (2000) 153.
16. Bruce M S, The anxiogenic effects of caffeine, Postgrad Med J, 66 (1990) S18.
17. Chiara Florio, Anita Prezioso, Aristotele Papaioannou & Rodolfo Vertua, Adenosine A1 receptors modulate anxiety in CD1 mice Psychopharmacology, 136 (1998) 311.
18. Ledent C, Vaugeois J M, Schiffmann S N, Pedrazzini T, El Yacoubi M, Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2A receptor, Nature, 388 (1997) 674.
19. Nickell P V & Uhde T W, Dose-response effects of intravenous caffeine in normal volunteers, Anxiety 1(1994) 161.
20. Johansson A, Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor, PNAS, 98 (2001) 9407.
21. Fredholm B B, Battig K, Holmen J, Nehlig A & Zvartau E, Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol Rev, 51 (1999) 83.